{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:48:01Z","timestamp":1788896881358,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12325-020-01553-1","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:46:01Z","timestamp":1605872761000},"page":"660-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland"],"prefix":"10.1007","volume":"38","author":[{"given":"Ayseg\u00fcl","family":"Aksan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Schoepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Juillerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Vavricka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramirez de Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gavata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neige","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-279X","authenticated-orcid":false,"given":"Barnaby","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"1553_CR1","unstructured":"GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17\u201330."},{"key":"1553_CR2","doi-asserted-by":"crossref","unstructured":"Juillerat P, Pittet V, Bulliard JL, et al. Prevalence of inflammatory bowel disease in the Canton of Vaud (Switzerland): a population-based cohort study. J Crohns Colitis. 2008;2(2):131\u201341.","DOI":"10.1016\/j.crohns.2007.10.006"},{"issue":"1","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12876-017-0681-y","volume":"17","author":"C B\u00e4hler","year":"2017","unstructured":"B\u00e4hler C, Vavricka SR, Schoepfer AM, Br\u00fcngger B, Reich O. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterol. 2017;17(1):138.","journal-title":"BMC Gastroenterol"},{"issue":"31","key":"1553_CR4","first-page":"49","volume":"47","author":"C Gasche","year":"2000","unstructured":"Gasche C. Complications of inflammatory bowel disease. Hepatogastroenterology. 2000;47(31):49\u201356.","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","volume":"12","author":"CW Wells","year":"2006","unstructured":"Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12(2):123\u201330.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1553_CR6","first-page":"104","volume":"26","author":"J Stein","year":"2013","unstructured":"Stein J, Dignass AU. Management of iron deficiency anemia in inflammatory bowel disease\u2014a practical approach. Ann Gastroenterol. 2013;26(2):104\u201313.","journal-title":"Ann Gastroenterol"},{"issue":"11\u201312","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","volume":"24","author":"S Kulnigg","year":"2006","unstructured":"Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn\u2019s disease. Aliment Pharmacol Ther. 2006;24(11\u201312):1507\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"1553_CR8","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1097\/MD.0000000000000963","volume":"94","author":"OH Nielsen","year":"2015","unstructured":"Nielsen OH, Ainsworth M, Coskun M, Weiss G. Management of iron-deficiency anemia in inflammatory bowel disease: a systematic review. Medicine. 2015;94:e963.","journal-title":"Medicine"},{"key":"1553_CR9","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJMra1401038","volume":"372","author":"C Camaschella","year":"2015","unstructured":"Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372:1832\u201343.","journal-title":"N Engl J Med"},{"issue":"37","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3748\/wjg.15.4659","volume":"15","author":"F Gomoll\u00f3n","year":"2009","unstructured":"Gomoll\u00f3n F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15(37):4659\u201365.","journal-title":"World J Gastroenterol"},{"key":"1553_CR11","doi-asserted-by":"crossref","unstructured":"Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211\u201322.","DOI":"10.1093\/ecco-jcc\/jju009"},{"issue":"3","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","volume":"6","author":"S Kaitha","year":"2015","unstructured":"Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6(3):62\u201372.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1553_CR13","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1093\/jn\/131.10.3146","volume":"132","author":"J Carrier","year":"2002","unstructured":"Carrier J, Aghdassi E, Cullen J, Allard JP. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr. 2002;132:3146\u201350.","journal-title":"J Nutr"},{"key":"1553_CR14","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1046\/j.1365-2036.2001.01113.x","volume":"15","author":"J Carrier","year":"2001","unstructured":"Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15:1989\u201399.","journal-title":"Aliment Pharmacol Ther"},{"key":"1553_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/00365520310000771","volume":"38","author":"K Erichsen","year":"2003","unstructured":"Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol. 2003;38:543\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"e0202460","DOI":"10.1371\/journal.pone.0202460","volume":"13","author":"A Mahalhal","year":"2018","unstructured":"Mahalhal A, Williams JM, Johnson S, et al. Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS One. 2018;13(10):e0202460.","journal-title":"PLoS One"},{"key":"1553_CR17","unstructured":"Compendium.ch. FERINJECT Inj L\u00f6s 100\u00a0mg\/2\u00a0ml. https:\/\/compendium.ch\/product\/1080875-ferinject-inj-los-100-mg-2ml\/mpro. Accessed 17 July 2020."},{"key":"1553_CR18","unstructured":"Compendium.ch. MONOFER Inj Inf Pr\u00e4p 100\u00a0mg\/ml (iH 12\/19). https:\/\/compendium.ch\/product\/1423093-monofer-inj-inf-prap-100-mg-ml\/mpro. Accessed 17 July 2020."},{"key":"1553_CR19","unstructured":"Compendium.ch. VENOFER Inj L\u00f6s 100\u00a0mg\/5\u00a0m. https:\/\/compendium.ch\/product\/46040-venofer-inj-los-100-mg-5ml\/mpro. Accessed 17 July 2020."},{"issue":"5","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2019.22450","volume":"323","author":"M Wolf","year":"2020","unstructured":"Wolf M, Rubin J, Achebe M, et al. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials. JAMA. 2020;323(5):432\u201343.","journal-title":"JAMA"},{"issue":"4","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/apt.15386","volume":"50","author":"TE Detlie","year":"2019","unstructured":"Detlie TE, Lindstr\u00f8m JC, Jahnsen ME, et al. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Aliment Pharmacol Ther. 2019;50(4):397\u2013406.","journal-title":"Aliment Pharmacol Ther"},{"key":"1553_CR22","doi-asserted-by":"crossref","unstructured":"Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846\u2013853.e1-2.","DOI":"10.1053\/j.gastro.2011.06.005"},{"issue":"5","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","volume":"103","author":"S Kulnigg","year":"2008","unstructured":"Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103(5):1182\u201392.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1553_CR24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/00365520902839667","volume":"44","author":"S Lindgren","year":"2009","unstructured":"Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44(7):838\u201345.","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/ajg.2013.335","volume":"108","author":"W Reinisch","year":"2013","unstructured":"Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108(12):1877\u201388.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","volume":"100","author":"O Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100(11):2503\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.14043","volume":"45","author":"A Aksan","year":"2017","unstructured":"Aksan A, I\u015f\u0131k H, Radeke HH, Dignass A, Stein J. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45(10):1303\u201318.","journal-title":"Aliment Pharmacol Ther"},{"key":"1553_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fphar.2011.00029","volume":"2","author":"MJ Nuijten","year":"2011","unstructured":"Nuijten MJ, Dubois DJ. Cost-utility analysis: current methodological issues and future perspectives. Front Pharmacol. 2011;2:29.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.diabres.2012.03.009","volume":"97","author":"K Khunti","year":"2012","unstructured":"Khunti K, Gillies CL, Taub NA, et al. A comparison of cost per case detected of screening strategies for type 2 diabetes and impaired glucose regulation: modelling study. Diabetes Res Clin Pract. 2012;97(3):505\u201313.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1553_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.fertnstert.2010.11.026","volume":"95","author":"P Katz","year":"2011","unstructured":"Katz P, Showstack J, Smith JF, et al. Costs of infertility treatment: results from an 18-month prospective cohort study. Fertil Steril. 2011;95(3):915\u201321.","journal-title":"Fertil Steril"},{"key":"1553_CR31","unstructured":"Bundesamt f\u00fcr Gesundheit BAG. Spezialit\u00e4tenliste (SL): Index der SL-Verzeichnisse. http:\/\/www.xn-spezialittenliste-yqb.ch\/. Accessed 17 July 2020."},{"key":"1553_CR32","unstructured":"Lohnanalyse. Krankenschwester\/Krankenpfleger in der Schweiz. https:\/\/www.lohnanalyse.ch\/ch\/loehne\/details\/krankenschwesterkrankenpfleger.html. Accessed 17 July 2020."},{"key":"1553_CR33","unstructured":"Kuhn und Bieri AG. BUTTERFLY\/FL\u00dcGELKAN\u00dcLE LL 21G, (0.8X19MM), GR\u00dcN, LEITUNG: 30CM, STERIL. https:\/\/www.kuhnbieri.ch\/de\/butterfly-flugelkanule-ll-21g-0-8x19mm-grun-leitung-30cm-steril.html. Accessed 17 July 2020."},{"key":"1553_CR34","unstructured":"Shop Apotheke. Venofix\u00ae A 0,8\/G21. https:\/\/www.shop-apotheke.ch\/de\/gesundheit\/5039573\/venofix-a-0-8-g21.htm. Accessed 17 July 2020."},{"key":"1553_CR35","unstructured":"Shop Apotheke. LEUKOMED sterile Pflaster 7.2\u00a0\u00d7\u00a05 cm. https:\/\/www.shop-apotheke.ch\/de\/gesundheit\/1050922\/leukomed-7-2-cm-x-5-cm-steril.htm. Accessed 17 July 2020."},{"key":"1553_CR36","unstructured":"RTS Info. Une \u00e9tude r\u00e9v\u00e8le ce que gagnent les m\u00e9decins en Suisse. https:\/\/www.rts.ch\/info\/suisse\/9953104-une-etude-revele-ce-que-gagnent-les-medecins-en-suisse.html. Accessed 17 July 2020."},{"key":"1553_CR37","unstructured":"FMH- Berufsverband. TARMED. https:\/\/www.fmh.ch\/themen\/ambulante-tarife\/tarmed.cfm. Accessed 17 July 2020."},{"key":"1553_CR38","doi-asserted-by":"crossref","unstructured":"Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010;4(6):642\u2013648.","DOI":"10.1016\/j.crohns.2010.07.008"},{"key":"1553_CR39","doi-asserted-by":"crossref","unstructured":"Madanchi M, Fagagnini S, Fournier N, et al. The relevance of vitamin and iron deficiency in patients with inflammatory bowel diseases in patients of the swiss IBD Cohort. Inflamm Bowel Dis. 2018;24(8):1768\u20131779.","DOI":"10.1093\/ibd\/izy054"},{"issue":"7","key":"1553_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/13696998.2020.1745535","volume":"23","author":"RF Pollock","year":"2020","unstructured":"Pollock RF, Muduma G. A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom. J Med Econ. 2020;23(7):751\u20139.","journal-title":"J Med Econ"},{"issue":"2","key":"1553_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/apt.14105","volume":"46","author":"NA Kennedy","year":"2017","unstructured":"Kennedy NA, Goodhand JR, Rampton DS. Editorial: which iron preparation for patients with IBD? Aliment Pharmacol Ther. 2017;46(2):194\u20135.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1553_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/apt.14126","volume":"46","author":"A Aksan","year":"2017","unstructured":"Aksan A, I\u015f\u0131k H, Radeke HH, Dignass A, Stein J. Editorial: which iron preparation for patients with IBD? Authors\u2019 reply. Aliment Pharmacol Ther. 2017;46(2):195\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/apt.14236","volume":"46","author":"W Reinisch","year":"2017","unstructured":"Reinisch W, Lindgren S. Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies. Aliment Pharmacol Ther. 2017;46(7):704\u20135.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1553_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/apt.14269","volume":"46","author":"A Aksan","year":"2017","unstructured":"Aksan A, I\u015f\u0131k H, Radeke HH, Dignass A, Stein J. Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies\u2014authors\u2019 reply. Aliment Pharmacol Ther. 2017;46(7):705\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"1553_CR45","doi-asserted-by":"crossref","unstructured":"Aksan A, I\u015f\u0131k H, Aksan S, Tu\u011fal D, Dignass A, Stein JM. P585 Evaluation and comparison of the safety profiles of different intravenous iron preparations and oral iron for treatment of iron deficiency anaemia: preliminary results from the IBD subgroup analysis. J Crohn\u2019s Colitis. 2020;14(Supplement_1):S490\u2013S490.","DOI":"10.1093\/ecco-jcc\/jjz203.713"},{"issue":"6","key":"1553_CR46","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ajg.2009.114","volume":"104","author":"S Kulnigg","year":"2009","unstructured":"Kulnigg S, Teischinger L, Dejaco C, Waldh\u00f6r T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol. 2009;104(6):1460\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1553_CR47","doi-asserted-by":"crossref","unstructured":"Riemsma R, Al M, Corro Ramos I, et al. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013;17(61):1\u2013236.","DOI":"10.3310\/hta17610"},{"issue":"7","key":"1553_CR48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12325-012-0035-7","volume":"29","author":"Y Liu","year":"2012","unstructured":"Liu Y, Wu EQ, Bensimon AG, et al. Cost per responder associated with biologic therapies for Crohn\u2019s disease, psoriasis, and rheumatoid arthritis. Adv Ther. 2012;29(7):620\u201334.","journal-title":"Adv Ther"},{"key":"1553_CR49","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fonc.2019.00814","volume":"9","author":"T Baguet","year":"2019","unstructured":"Baguet T, Verhoeven J, De Vos F, Goethals I. Cost-effectiveness of [18F] fluoroethyl-l-tyrosine for temozolomide therapy assessment in patients with glioblastoma. Front Oncol. 2019;9:814.","journal-title":"Front Oncol"},{"issue":"1","key":"1553_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40273-019-00829-x","volume":"38","author":"E Wehler","year":"2020","unstructured":"Wehler E, Boytsov N, Nicolay C, Herrera-Restrepo O, Kowal S. A budget impact and cost per additional responder analysis for baricitinib for the treatment of moderate-to-severe rheumatoid arthritis in patients with an inadequate response to tumor necrosis factor inhibitors in the USA. Pharmacoeconomics. 2020;38(1):39\u201356.","journal-title":"Pharmacoeconomics"},{"key":"1553_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41927-018-0011-1","volume":"2","author":"V Strand","year":"2018","unstructured":"Strand V, Elaine Husni M, Betts KA, et al. Network meta-analysis and cost per responder of targeted immunomodulators in the treatment of active psoriatic arthritis. BMC Rheumatol. 2018;2:3.","journal-title":"BMC Rheumatol"},{"key":"1553_CR52","doi-asserted-by":"crossref","unstructured":"Rajagopalan K, Bloudek L, Marvel J, Dembek C, Kavati A. Cost-effectiveness of twice-daily indacaterol\/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US. Int J Chron Obstruct Pulmon Dis. 2018;13:3867\u20133877.","DOI":"10.2147\/COPD.S177097"},{"key":"1553_CR53","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Betts KA, Sundaram M, Thomason D, Signorovitch JE. Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-na\u00efve patients with psoriasis. J Am Acad Dermatol. 2016;75(4):740\u2013746.","DOI":"10.1016\/j.jaad.2016.05.040"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01553-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T14:27:44Z","timestamp":1640010464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01553-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: Readers are alerted that concerns have been raised regarding the study design and statistical analysis in this manuscript. These concerns are being considered by Editors and a further editorial response will follow the resolution of these issues.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: The concerns regarding this study have been considered to be part of the scientific debate and as such they have been published in the form of a peer reviewed letter to the editor. The authors response has also been published. The Editors consider this matter closed at this time.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}